| NDC Code | 0406-1923-03 |
|---|
| Package Description | 30 TABLET in 1 BOTTLE (0406-1923-03) |
|---|
| Product NDC | 0406-1923 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Buprenorphine Hcl And Naloxone Hcl |
|---|
| Non-Proprietary Name | Buprenorphine And Naloxone |
|---|
| Dosage Form | TABLET |
|---|
| Usage | SUBLINGUAL |
|---|
| Start Marketing Date | 20130222 |
|---|
| End Marketing Date | 20210228 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA203136 |
|---|
| Manufacturer | SpecGx LLC |
|---|
| Substance Name | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE |
|---|
| Strength | 2; .5 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Partial Opioid Agonists [MoA],Partial Opioid Agonist [EPC],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
|---|
| DEA Schedule | CIII |
|---|